The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

28 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure-Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode.EBI
University Of Strathclyde
Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells.EBI
University Of Tennessee Health Science Center
Discovery of potent inhibitors of the lysophospholipase autotaxin.EBI
Babraham Research Campus
Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature.EBI
University Of Strathclyde
Vinyl sulfone analogs of lysophosphatidylcholine irreversibly inhibit autotaxin and prevent angiogenesis in melanoma.EBI
The University Of Georgia
Imidazopyridine- and purine-thioacetamide derivatives: potent inhibitors of nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1).EBI
Ku Leuven
Autotaxin inhibition: development and application of computational tools to identify site-selective lead compounds.EBI
The University Of Memphis
The chemical synthesis of metabolically stabilized 2-OMe-LPA analogues and preliminary studies of their inhibitory activity toward autotaxin.EBI
Technical University Of Lodz
Pharmacophore development and application toward the identification of novel, small-molecule autotaxin inhibitors.EBI
The University Of Memphis
Aromatic phosphonates inhibit the lysophospholipase D activity of autotaxin.EBI
The University Of Utah
Structure-based design of novel boronic acid-based inhibitors of autotaxin.EBI
The Netherlands Cancer Institute
Synthesis and structure-activity relationships of tyrosine-based inhibitors of autotaxin (ATX).EBI
University Of Virginia
Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid.EBI
University Of Tennessee Health Science Center
Discovery and optimization of boronic acid based inhibitors of autotaxin.EBI
Institute
Characterization of non-lipid autotaxin inhibitors.EBI
The University Of Memphis
Optimization of a pipemidic acid autotaxin inhibitor.EBI
The University Of Memphis
Identification of Darmstoff analogs as selective agonists and antagonists of lysophosphatidic acid receptors.EBI
University Of Tennessee Health Science Center
Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands.EBI
University Of Tennessee Health Science Center
Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.BDB
Human Biomolecular Research Institute
Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice.BDB
University Of Washington At Seattle
Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes.BDB
Bristol-Myers Squibb
Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.BDB
Parke-Davis Pharmaceutical Research
Synthesis and anti-HIV-1 activity of thio analogues of dihydroalkoxybenzyloxopyrimidines.BDB
Sapienza University Of Rome